China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
22 hedge funds and large institutions have $339M invested in China Biologic Products Holdings, Inc. in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 21 → 22 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $345M → $339M (-$6.11M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$1.86M |
| 2 |
Renaissance Technologies
New York
|
+$693K |
| 3 |
Morgan Stanley
New York
|
+$641K |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$351K |
| 5 |
Two Sigma Investments
New York
|
+$239K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.16M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$307K |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$211K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$137K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$134K |
CBPO Hedge Fund Activity: Q4 2013 in Review
22 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q4 2013, worth a combined $339M — down 1.8% from $345M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CBPO positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Letko, Brosseau & Associates, adding an estimated $1.86M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $5.16M sold.
- 22 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q4 2013, up from 21 in Q3 2013.
- Funds reported $339M of China Biologic Products Holdings, Inc. stock for Q4 2013, down 1.8% quarter-over-quarter.
- 4 funds opened new China Biologic Products Holdings, Inc. positions in Q4 2013 and 3 closed out, a net change of +1 holder.
- The largest China Biologic Products Holdings, Inc. buyer in Q4 2013 was Letko, Brosseau & Associates, an estimated $1.86M added.
- The largest China Biologic Products Holdings, Inc. seller in Q4 2013 was T. Rowe Price Associates, an estimated $5.16M sold.
Based on aggregated 13F filings for Q4 2013.